High remission rates for new CLL treatment

CLL from a patient and physician perspective

Introduction to medical data protection

Privacy and Data Protection within European law

Your rights as a patient

Consent as the basis for using patient data

The changing landscape of the young investigator meeting at iwCLL 2015

Ethnic variations in CLL prevalence

Risk of bleeding-related adverse events in ibrutinib treated CLL patients

Crystallography of the B-cell receptor immunoglobulin in CLL patients

Epidemiology of CLL: Interlymph consortium and genome-wide sequencing studies

Harmonisation of CLL diagnosis and detection of residual disease monitoring by flow cytometry